Lack of targeted drug delivery reduces the therapeutic-to-toxicity ratio thus limiting medical therapy.  This limitation is particularly evident within oncology where systemic administration of cytostatic drugs affects all dividing cells imposing dose limitations.  Hence, it exists a clear need for more efficient delivery of therapeutic drugs at the disease target with negligible toxicity to healthy tissue.  This challenge has to a certain extent been accommodated by encapsulating drugs in a shell protecting healthy tissue en route to the diseased volume.  Such protective shells may include a number of different colloidal particles such as liposomes or other lipid dispersions, and polymer particles.  However, development of such drug delivery particles has faced two opposing challenges: efficient release of the encapsulated drug at the diseased site while maintaining slow non-specific degradation or passive diffusion in healthy tissue.  At present, this constitutes the main challenge in drug delivery (Drummond, Meyer et al.  1999). 
Ultrasound (US) has been suggested as a method to trigger specific drug release (Pitt, Husseini et al.  2004).  This may allow the engineering of robust particles protecting healthy tissue while in circulation, accumulating in the diseased volume and releasing the payload on exposure to acoustic energy.  Also, US is known to increase cell permeability thus providing a twofold effect: drug carrier disruption and increased intracellular drug uptake (Larina, Evers et al.  2005; Larina, Evers et al.  2005). 
Currently, four main types of US responsive particles are known: micelles, gas-filled liposomes, microbubbles and liposomes.  Micelles are non-covalently self-assembled particles typically formed by molecules containing one part that is water-soluble and one that is fat soluble.  The monomer aqueous solubility is typically in the mM range and at a critical concentration; micelles are formed shielding the fat soluble part from the aqueous phase.  Micelle formation and disruption is therefore an equilibrium process controlled by concentration, making these particles rather unstable and less suitable for drug delivery.  In addition, limited drug types can be encapsulated.  Gas-filled liposomes and microbubbles are highly US responsive but too large (˜1 μm) for efficient accumulation in e.g. tumour tissue.  In contrast, liposomes or other lipid dispersions may encapsulate a broad range of water soluble and fat soluble drugs, as well as efficiently accumulate in e.g. tumour tissue.  However, reports on ultrasound sensitive liposomes are scarce. 
Lin and Thomas (Lin and Thomas 2003) report that when liposome membranes are altered by the addition of phospholipid grafted polyethylene glycol (PEG-lipid) or non-ionic surfactants, the liposome is more responsive to US.  The present applicant recently identified a synergistic interplay between liposomal PEG-lipid content and liposome size with respect to US sensitivity (NO20071688 and NO20072822, incorporated herein by reference).  Here, liposomes with both high PEG-lipid content and small size showed synergistically increased US responsivity or sonosensitivity and improved drug release properties. 
Long-chain alcohols may also be incorporated in phospholipid bilayers.  The alcohol has one part with affinity for water (hydroxyl group) and another with affinity for oily or lipidic environments (hydrocarbon moiety).  When added to a liposome dispersion some alcohol molecules remain in the aqueous phase, whilst others are incorporated in the phospholipid membrane.  The extent of incorporation depends on the alcohol chain length.  The longer the chain length, the more molecules will be captured within the membrane (Aagaard, Kristensen et al.  2006).  The fact that organic alcohols can penetrate membranes also has an implication on local and general anaesthesia in animals (Lee 1976). 
The effect of alcohols on the liposomal membrane properties is remarkably different depending on the alcohol chain length.  The membrane can be made “thinner” by inclusion of short chain alcohols (Rowe and Campion 1994; Tierney, Block et al.  2005) and the gel-to-liquid crystalline phase transition temperature of the membrane lowered by the addition of decanol (Thewalt and Cushley 1987).  Interestingly, octanol which has a shorter chain is even more efficient to lower the phase transition temperature. 
Phosphatidyletanolamine (PE) is the main constituent of one important class of pH sensitive liposomes (for a review see Drummond et al, Prog Lipid Res 2000; 39(5): 409-460).  pH sensitive liposomes are designed to release its payload when exposed to acidic environments. 
In a recent study conducted by the current applicant, it was shown for the first time that the antitumoural effect of liposomal doxorubicin (Caelyx®) could be enhanced when combined with ultrasound (Myhr and Moan 2006).  However, liposomal doxorubicin (Caelyx® or Doxil®) is not engineered for ultrasound mediated drug release and shows a rather low drug release in vitro (see e.g. WO2008120998, incorporated herein in its entirety by reference). 
The current inventors disclose that the sonosensitivity of drug delivery particles is surprisingly improved by the incorporation of non-lamellar forming lipids, more particularly, inverted structure forming lipids (ISF lipids).  Even more surprising, the combination of ISF lipids and alcohols further improved sonosensitivity synergistically.  The current invention may be employed to efficiently deliver drugs in a defined tissue volume to combat localized diseases.  Such particles may passively or actively accumulate in the target tissue and the drug payload may be dumped in the tissue by means of ultrasound thereby increasing the therapeutic-to-toxicity ratio.